Skip to main content
Quiz

Quiz: Real-World Effectiveness of Enasidenib for Relapsed/Refractory AML

 

 

True or False: First-line enasidenib demonstrates worse efficacy in the real-world setting than in clinical trials for the treatment of relapsed/refractory IDH2-mutated AML.